Wednesday, December 12, 2018

Biotech

Home Biotech

Anthera Pharma (NASDAQ: ANTH) Up 30% on Analyst Price Target.

Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is having a strong start to the trading session this morning, and for good reason. The company was the center of...

Innovus Pharmaceuticals Inc. (OTCMKTS:INNV)’s Q3 Triggers $0.65 Target

Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) rebound from this year’s lows continued in Monday’s trading session. The stock was up by 10.8% as investors...
Regen BioPharma Inc. (OTCMKTS:RGBP)

Regen BioPharma Inc. (OTCMKTS:RGBP) Spikes

Regen BioPharma Inc. (OTCMKTS:RGBP) Regen BioPharma Inc. (OTCMKTS:RGBP) shares gained 21.6% after the CEO, David Koos, provided an update on how they intend to pursue...

TITAN MEDICAL INC (OTCMKTS:TITXF) Drops After Pricing

TITAN MEDICAL INC (OTCMKTS:TITXF) Shares of TITAN MEDICAL INC (OTCMKTS:TITXF) fell 17.3% after the development stage company announced the pricing of previously announced marketed offerings....

Delcath Systems, Inc. (OTCMKTS:DCTHD) Explodes After Stellar Q3 Results

Delcath Systems, Inc. (OTCMKTS:DCTHD) Shares of Delcath Systems, Inc. (OTCMKTS:DCTHD) nearly doubled in market value after the interventional oncology company reported impressive financial results for...
US Stem Cell Inc. (OTCMKTS:USRM)

US Stem Cell Inc. (OTCMKTS:USRM) Financial Results Beat Estimates

US Stem Cell Inc. (OTCMKTS:USRM) US Stem Cell Inc. (OTCMKTS:USRM) traded higher after reporting third quarter financial results that beat Wall Street expectations. The stock...

Helius Medical Technologies Inc. (OTCMKTS:HSDT) Reports Positive Trial Results

Helius Medical Technologies Inc. (OTCMKTS:HSDT) Shares of Helius Medical Technologies Inc.(OTCMKTS:HSDT) fell 25.33% despite the company reporting positive results from its Registration Clinical trial for Traumatic...

Lexaria Bioscience Corp (OTCMKTS:LXRP) Spikes

Lexaria Bioscience Corp (OTCMKTS:LXRP) Lexaria Bioscience Corp (OTCMKTS:LXRP) was a big mover just days after the U.S Patent and Trademark Office granted it a new...

Lexaria Bioscience Corp (OTCMKTS:LXRP) Strengthens Intellectual Property Portfolio

Lexaria Bioscience Corp (OTCMKTS:LXRP) Shares of Lexaria Bioscience Corp (OTCMKTS:LXRP) gained 14.1% after the drug delivery platform innovator announced the acquisition of 100% ownership interest...

Pharmacyte Biotech Inc. (OTCMKTS:PMCB) Working On Cannabis-Based Therapies

Pharmacyte Biotech Inc. (OTCMKTS:PMCB) Pharmacyte Biotech Inc. (OTCMKTS:PMCB) fell 25%, days after announcing its research partner had achieved an important milestone in the use of...

EDITOR PICKS